Results 1 to 10 of about 1,087,976 (160)

Survey and analysis of the availability and affordability of essential drugs in Hefei based on WHO / HAI standard survey methods [PDF]

BMC Public Health, 2020
Background The 2018 edition of the National Essential drugs List came into effect in September 2018. Relevant policies require that all primary medical and health institutions should supply national essential drugs, while secondary and tertiary medical ...
Zuojun Dong, Qiucheng Tao, Guojun Sun
doaj   +2 more sources

Essential Drugs

Annals of Medicine, 1993
Availability of an appropriate selection and regular supply of affordable drugs that are efficacious, safe and of good quality, is a prerequisite for any operative health care system. In most of the industrialized countries a variety of drugs are usually available in sufficient quantity and some drugs may even be over-used in medical therapy, yet half ...
exaly   +3 more sources

The evidence-informed decision-making process of the National Essential Medicines List Committee and Essential Drugs Programme [PDF]

Journal of the Colleges of Medicine of South Africa
Amanda Brewer, Janine Jugathpal, Kim MacQuilkan, Marc Blockman, Andrew Gray, Tamara Kredo, Reneé de Waal, Lesley Robertson   +7 more
doaj   +2 more sources

Are drugs for rare diseases "essential"?

Bulletin of the World Health Organization, 2006
In 1977, the first report of the WHO Expert Committee on the Use of Essential Drugs defined essential drugs as those needed to satisfy the health-care needs of the majority of the population. This was done in order to fulfil a mandate to assist Member States in selecting and obtaining essential medicaments for their populations.
Marcus M Reidenberg
doaj   +3 more sources

Rare essentials: drugs for rare diseases as essential medicines

Bulletin of the World Health Organization, 2006
Since 1977, the WHO Model List of Essential Medicines (EML), published by WHO, has provided advice for Member States that struggle to decide which pharmaceutical technologies should be provided to patients within their public health systems.
Pieter Stolk, Marjolein JC Willemen, Hubert GM Leufkens   +2 more
doaj   +5 more sources

A third-line antiretroviral therapy register to track patient clinical and virological outcomes

South African Medical Journal, 2022
-
K Naidoo, J Ramruthan, M Reddy, R Lancaster   +3 more
doaj   +1 more source

The global shortage of essential drugs during the COVID-19 pandemic: Evidence based on aggregated media and social media reports

Journal of Nature and Science of Medicine, 2022
Background: Implications from accumulated bodies of commentaries and media/social-media reports highlight the drug shortage during the COVID-19 pandemic. In this special report, the relation between drug shortage and response measures is discussed in the
Mohammed Salahuddin, Dilshad Manzar, Aleem Unissa, Seithikurippu R Pandi-Perumal, Ahmed S BaHammam   +4 more
doaj   +1 more source

Access to Medicines for Non-Communicable Diseases (NCDS) during COVID-19 in Kenya: A Descriptive Commentary

Health Systems & Reform, 2021
Evidence shows that those with non-communicable diseases (NCDs) are at higher risk for serious illness and mortality from COVID-19. In Kenya, about 50% of the COVID-19 patients who have died had an NCD.
Zana Wangari Kiragu, Gladwell Gathecha, Martin K. Mwangi, Zachary Ndegwa, Sonak Pastakia, Daniel Nyagah, Richard N. Cizungu, Mariana Takah Mutwiri, Meshack Ndolo, Veronika J. Wirtz   +9 more
doaj   +1 more source

Knowledge, attitude and practices of rational use of medicines among interns in a tertiary care teaching hospital in Telangana

Asian Journal of Medical Sciences, 2021
Background: Rational use of drugs significantly impacts the treatment outcomes and the cost of health care. Most of the medical students are exposed to rational use of medicines and prescription writing during their second year but it is only during ...
Kranti Tekulapally
doaj   +1 more source

Using government data to understand the use and availability of medicines for hypertension and diabetes: lessons from Peru

Journal of Pharmaceutical Policy and Practice, 2022
Background Regular measurement of the availability and use of key medicines for non-communicable diseases allows the tracking of progress to achieve equitable access to medicines. Using a country-level public sector monitoring system for medicine supply,
Janeth Tenorio-Mucha, María Lazo-Porras, Jessica Zafra, Margaret Ewen, David Beran   +4 more
doaj   +1 more source